Ursula Wiedermann

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 17

Top Topics

Respiratory Syndrome Coronavirus

Natural Killer Cells

Top Venues

Scientific reports

This page only lists publications with an associated author ORCID identifier.

Publications

Angelika Wagner, Erika Garner-Spitzer, Claudia Auer, Pia Gattinger, Ines Zwazl, René Platzer, Maria Orola-Taus, Peter Pichler, Fabian Amman, Andreas Bergthaler, Johannes B Huppa, Hannes Stockinger, Christoph C Zielinski, Rudolf Valenta, Michael Kundi, Ursula Wiedermann
Breakthrough Infections in SARS-CoV-2-Vaccinated Multiple Myeloma Patients Improve Cross-Protection against Omicron Variants. Vaccines 12 (5) (2024)
Heimo Breiteneder, Ursula Wiedermann
Legends of allergy and immunology: Otto Scheiner. Allergy (2024)
Angelika Wagner, Erika Garner-Spitzer, Claudia Auer, Pia Gattinger, Ines Zwazl, René Platzer, Maria Orola-Taus, Peter Pichler, Fabian Amman, Andreas Bergthaler, Johannes B Huppa, Hannes Stockinger, Christoph C Zielinski, Rudolf Valenta, Michael Kundi, Ursula Wiedermann
Breakthrough Infections in SARS-CoV-2-Vaccinated Multiple Myeloma Patients Improve Cross-Protection against Omicron Variants. Vaccines 12 (5) (2024)
Joshua Tobias, Marina Maglakelidze, Zoran Andrić, Dinara Ryspayeva, Iurie Bulat, Ivan Nikolić, Zoran Petrovic, Tanuj Chawla, Rajnish Nagarkar, Erika Garner-Spitzer, Christoph C Zielinski, Leslie Mi Ok Chong, Bonnie Nixon, Nicholas J Ede, Sharon Yavrom, Michael Kundi, Ursula Wiedermann
Phase II trial of HER-Vaxx, a B cell peptide-based vaccine, in HER2-overexpressing advanced gastric cancer patients under platinum-based chemotherapy (HERIZON). Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Heimo Breiteneder, Ursula Wiedermann
Legends of allergy and immunology: Otto Scheiner. Allergy 79 (8) (2024)
Nora Geissler, Maria Orola, Masoumeh Alinaghi, Alexander D Nardo, Thomas M Stulnig, Joana Séneca, Anna Schmid, Elke Korb, Tatjana Svoboda, Erika Garner-Spitzer, Michael Kundi, Monika Ehling-Schulz, Irma Schabussova, Aleksandra Inic-Kanada, Ursula Wiedermann
Obesity increases allergic airway inflammation that can be successfully treated by oral tolerance. Allergy 79 (2) (2023)
Nora Geissler, Maria Orola, Masoumeh Alinaghi, Alexander D Nardo, Thomas M Stulnig, Joana Séneca, Anna Schmid, Elke Korb, Tatjana Svoboda, Erika Garner-Spitzer, Michael Kundi, Monika Ehling-Schulz, Irma Schabussova, Aleksandra Inic-Kanada, Ursula Wiedermann
Obesity increases allergic airway inflammation that can be successfully treated by oral tolerance. Allergy (2023)
Nora Geissler, Maria Orola, Masoumeh Alinaghi, Alexander D Nardo, Thomas M Stulnig, Joana Séneca, Anna Schmid, Elke Korb, Tatjana Svoboda, Erika Garner-Spitzer, Michael Kundi, Monika Ehling-Schulz, Irma Schabussova, Aleksandra Inic-Kanada, Ursula Wiedermann
Obesity increases allergic airway inflammation that can be successfully treated by oral tolerance. Allergy 79 (2) (2023)
Georgii Brazhnikov, Evgenii Smolnikov, Alla Litovkina, Tianchi Jiang, Artem A Shatilov, Inna Tulaeva, Mikhail Tulaev, Alexander V Karaulov, Alina Poroshina, Yury V Zhernov, Margarete Focke-Tejkl, Milena Weber, Oluwatoyin Akinfenwa, Olga Elisyutina, Sergey M Andreev, Igor Shilovskiy, Nadezhda Shershakova, Valeriy V Smirnov, Elena Fedenko, Tatiana Sergeevna Lepeshkova, Evgeny Cronidovich Beltyukov, Veronika Victorovna Naumova, Michael Kundi, Khaitov M R, Ursula Wiedermann, Rudolph Valenta, Raffaela Campana
Natural human Bet v 1-specific IgG antibodies recognize non-conformational epitopes whereas IgE reacts with conformational epitopes. Allergy (2023)
Nora Geissler, Maria Orola, Masoumeh Alinaghi, Alexander D Nardo, Thomas M Stulnig, Joana Séneca, Anna Schmid, Elke Korb, Tatjana Svoboda, Erika Garner-Spitzer, Michael Kundi, Monika Ehling-Schulz, Irma Schabussova, Aleksandra Inic-Kanada, Ursula Wiedermann
Obesity increases allergic airway inflammation that can be successfully treated by oral tolerance. Allergy 79 (2) (2023)
Pia Gattinger, Bernhard Kratzer, Inna Tulaeva, Katarzyna Niespodziana, Anna Ohradanova-Repic, Laura Gebetsberger, Kristina Borochova, Erika Garner-Spitzer, Doris Trapin, Gerhard Hofer, Walter Keller, Isabella Baumgartner, Amra Tancevski, Khaitov M R, Alexander Karaulov, Hannes Stockinger, Ursula Wiedermann, Winfried F Pickl, Rudolph Valenta
Vaccine based on folded receptor binding domain-PreS fusion protein with potential to induce sterilizing immunity to SARS-CoV-2 variants. Allergy 77 (8) (2022)
Joshua Tobias, Mirjana Drinić, Anna Schmid, Anastasiya Hladik, Martin L Watzenböck, Claire Battin, Erika Garner-Spitzer, Peter Steinberger, Michael Kundi, Sylvia Knapp, Christoph C Zielinski, Ursula Wiedermann
Combined Vaccination with B Cell Peptides Targeting Her-2/neu and Immune Checkpoints as Emerging Treatment Option in Cancer. Cancers 14 (22) (2022)
Claire Battin, Gabriel Kaufmann, Judith Leitner, Joshua Tobias, Ursula Wiedermann, Alexander Rölle, Marten Meyer, Frank Momburg, Peter Steinberger
NKG2A-checkpoint inhibition and its blockade critically depends on peptides presented by its ligand HLA-E. Immunology 166 (4) (2022)
Angelika Wagner, Angela Guzek, Johanna Ruff, Joanna Jasinska, Ute Scheikl, Ines Zwazl, Michael Kundi, Hannes Stockinger, Maria R Farcet, Thomas R Kreil, Eva Hoeltl, Ursula Wiedermann
Neutralising SARS-CoV-2 RBD-specific antibodies persist for at least six months independently of symptoms in adults. Communications medicine 1 (2021)
Beate Jahn, Gaby Sroczynski, Martin Bicher, Claire Rippinger, Nikolai Mühlberger, Júlia Santamaria, Christoph Urach, Michael Schomaker, Igor Stojkov, Daniela Schmid, Guenter Weiss, Ursula Wiedermann, Monika Redlberger-Fritz, Christiane Druml, Mirjam E E Kretzschmar, Maria Paulke-Korinek, Herwig Ostermann, Caroline Czasch, Gottfried Endel, Wolfgang Bock, Nikolas Popper, Uwe Siebert
Targeted COVID-19 Vaccination (TAV-COVID) Considering Limited Vaccination Capacities-An Agent-Based Modeling Evaluation. Vaccines 9 (5) (2021)
Lukas Richter, Daniela Schmid, Elisabeth Eva Kanitz, Ines Zwazl, Eva Pöllabauer, Joanna Jasinska, Heinz Burgmann, Michael Kundi, Ursula Wiedermann
Invasive pneumococcal diseases in children and adults before and after introduction of the 10-valent pneumococcal conjugate vaccine into the Austrian national immunization program. PloS one 14 (1) (2019)
Annika De Sousa Linhares, Claire Battin, Sabrina Jutz, Judith Leitner, Christine Hafner, Joshua Tobias, Ursula Wiedermann, Michael Kundi, Gerhard J Zlabinger, Katharina Grabmeier-Pfistershammer, Peter Steinberger
Therapeutic PD-L1 antibodies are more effective than PD-1 antibodies in blocking PD-1/PD-L1 signaling. Scientific reports 9 (1) (2019)